Scarica l'app Stockscreener
0.1802
6.88%
-0.0148
Gossamer Bio Inc Borsa (GOSS) Ultime notizie
Gossamer Bio focuses on respiratory pipeline as markets weigh biotech valuations - AD HOC NEWS
GOSSGossamer Bio Inc Dividends - Finviz
Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash? - Stocktwits
Price to earnings forward of Gossamer Bio, Inc. – DUS:4GB - TradingView
Gossamer Bio (GOSS) Stock Fair Value Moves Lower After Mixed Analyst Target Changes - Yahoo Finance
D.E. Shaw discloses 8.3% Gossamer Bio (GOSS) ownership stake - Stock Titan
Form 13D/A Gossamer Bio For: 1 July By Investing.com - Investing.com Canada
GOSS: Gossamer Bio Sets Initial Conversion Rate for Convertible Notes - GuruFocus
Gossamer Bio sets conversion rate for 2030 convertible notes By Investing.com - Investing.com Nigeria
Gossamer Bio sets conversion rate for 2030 convertible notes - Investing.com
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants - marketscreener.com
Gossamer Bio (NASDAQ: GOSS) sets note conversion rate and warrant exercise price - Stock Titan
Gossamer Bio fixes note conversion at $0.19, warrants at $0.34 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Gossamer Bio, Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Enterprise value to revenue forward of Gossamer Bio, Inc. – NASDAQ:GOSS - TradingView
Enterprise value to EBITDA forward of Gossamer Bio, Inc. – NASDAQ:GOSS - TradingView
Price to book forward of Gossamer Bio, Inc. – NASDAQ:GOSS - TradingView
Price to sales forward of Gossamer Bio, Inc. – NASDAQ:GOSS - TradingView
Enterprise value to EBIT forward of Gossamer Bio, Inc. – SWB:4GB - TradingView
Price to sales forward of Gossamer Bio, Inc. – SWB:4GB - TradingView
Enterprise value to revenue forward of Gossamer Bio, Inc. – SWB:4GB - TradingView
Price to earnings forward of Gossamer Bio, Inc. – SWB:4GB - TradingView
H.C. Wainwright cuts Gossamer Bio stock price target to $2 on debt exchange By Investing.com - Investing.com Australia
GOSSAMER BIO INC (GOSS) Stock Chart - ChartMill
H.C. Wainwright cuts Gossamer Bio stock price target to $2 on debt exchange - Investing.com Nigeria
Gossamer Bio Price Target Cut to $2.00/Share From $5.00 by HC Wainwright & Co. - Moomoo
Gossamer Bio, Inc. (GOSS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
GOSS Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Gossamer Bio, Inc. (GOSS) Investigation: Bronstein, Gewirtz & Gro - The National Law Review
Gossamer Bio, Inc. Actuals & Estimates (NASDAQ:GOSS) - TradingView
Gossamer Bio Inc (GOSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bronstein, Gewirtz & Grossman, LLC Is Investigating Gossamer Bio, Inc. (GOSS) And Encourages Investors to Connect - ACCESS Newswire
GOSS News | GOSSAMER BIO INC (NASDAQ:GOSS) - ChartMill
Gossamer Bio Inc (GOSS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Gossamer Bio opens the week with chart pressure, shares trade near Nasdaq penny range - AD HOC NEWS
Gossamer Bio Inc (GOSS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Gossamer Bio, Inc. (GOSS) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Gossamer Bio, Inc. (GOSS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Gossamer Bio Inc (NASDAQ: GOSS) Share Price, GOSS Stock News, GOSS Share Price & Updates - Kalkine
Gossamer Bio (GOSS) Stock Faces Mixed Analyst Target Changes On Funding Risk - Yahoo Finance
Gossamer Bio Insiders Are Down US$45k But Regain Some Losses - simplywall.st
Gossamer Bio Inc (GOSS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
683 Capital Management, LLC Acquires Significant Stake in Gossamer Bio Inc - GuruFocus
Gossamer Bio Inc (GOSS) Q1 2026 Earnings Call Highlights: Strategic Debt Reduction and ... By GuruFocus - Investing.com Canada
Gossamer Bio Inc (GOSS) Q1 2026 Earnings Call Highlights: Strate - GuruFocus
Gossamer Bio Inc. has officially announced the final tender results for its exchange offer and consent solicitation regarding its outstanding convertible notes. - Bitget
GOSS: Gossamer Bio Concludes Exchange Offer for Convertible Seni - GuruFocus
Gossamer Bio Inc (GOSS) Institutional Confidence - TradingKey
Gossamer Bio Inc (GOSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Gossamer Bio completes exchange offer for convertible notes By Investing.com - Investing.com South Africa
Gossamer Bio completes exchange offer for convertible notes - Investing.com
Gossamer Bio Inc (GOSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Gossamer Bio final tender results: $72M new notes, 317.6M shares available; $18.95M old notes remain - TradingView
Gossamer Bio (NASDAQ: GOSS) swaps most 2027 converts into 2030 debt and equity - Stock Titan
Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes - Business Wire
1.66%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):